Kelly A. Kramer Joins Gilead Sciences’ Board of Directors
August 23 2016 - 8:55AM
Business Wire
Gilead Sciences, Inc. (Nasdaq:GILD) announced today that
Kelly A. Kramer has been appointed to the company’s Board of
Directors and Audit Committee.
Ms. Kramer is currently Executive Vice President and Chief
Financial Officer of Cisco Systems, Inc., which designs and sells
products, services and solutions to securely connect everyone and
everything. She previously served for 20 years in senior finance
positions at General Electric, including as Chief Financial Officer
of GE Healthcare’s Healthcare Systems Business. She is a member of
the board of the Silicon Valley Chapter of City Year, a non-profit
organization that provides educational support for at-risk students
in poor communities.
“We are very pleased to welcome Kelly Kramer to the Board of
Directors of Gilead Sciences,” said John Martin, PhD, Executive
Chairman of Gilead’s Board of Directors. “Kelly’s deep financial
expertise in the technology and healthcare industries, including
mergers and acquisitions, will be valuable as Gilead continues to
grow across multiple therapeutic areas and around the world. I look
forward to the contributions and insights that she will bring to
the Board.”
About Gilead
Sciences
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases worldwide. Gilead
has operations in more than 30 countries worldwide, with
headquarters in Foster City, California.
For more information on Gilead Sciences,
please visit the company’s website at www.gilead.com, follow
Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160823005469/en/
Gilead Sciences, Inc.InvestorsSung Lee,
650-524-7792orMediaMichele Rest, 650-577-6935
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024